Axogen Inc (AXGN) Stock Price, Quote & News

Company Profile

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral...

Industry: Medical Devices

Sector: Healthcare

Phone: 386 462 6800

Fax: 386 462 6801

Website: www.axogeninc.com

Address:

13631 Progress Boulevard, Suite 400, Alachua, United States

dustin1101 Dec. 23 at 9:09 PM

$AXGN Next stop $38+ IMO. What a beast. $45 right now and they can have all my shares 😉.

0 · Reply

freeindeed Dec. 22 at 9:12 PM

$AXGN Here's a lump of coal for all you shorts. Sorry, you'll have to divide it.💩 Merry Christmas longs!

1 · Reply

isaacwilliams33 Dec. 17 at 8:32 PM

$AXGN ge

0 · Reply

dustin1101 Dec. 17 at 7:21 PM

$AXGN big $ deciding it’s not worth waiting any longer. In the face of a red mkt. I added some early today and on the first dip. Back to just over 10K shares strong.

0 · Reply

Niddi Dec. 17 at 5:50 PM

$AXGN Manipulated down after approval. Should gain at least 20-25% by the year end. One more good news will take it above 40. Just my opinion.

0 · Reply

dustin1101 Dec. 17 at 3:08 PM

$AXGN popping wood first thing today after the last two days is a good sign. Nice volume 👀

0 · Reply

Niddi Dec. 15 at 7:53 PM

$AXGN Is it alive?

0 · Reply

dustin1101 Dec. 15 at 5:08 PM

$AXGN If you’re making investing decisions based on AI generated crap like this below.. 🤦🏻‍♂️ wow.. ⬇️⬇️⬇️

0 · Reply

BioTechHealthX Dec. 13 at 11:22 PM

$AXGN Axogen Inc. (NASDAQ: AXGN) develops biologic technologies for peripheral nerve regeneration. This in-depth background explains how its science works, why adoption is complex, and what investors often miss. https://biotechhealthx.com/biotech-news/axogen-inc-axgn-the-nerve-repair-company-most-investors-dont-fully-understand/

1 · Reply

Niddi Dec. 12 at 8:57 PM

$AXGN It’s amazing how easily a stock can be manipulated.

0 · Reply

Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)

Dec 3, 2025, 6:53 PM EST - 21 days ago

FDA approves Axogen's nerve repair graft

Dec 1, 2025, 12:33 PM EST - 23 days ago

Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen

Nov 5, 2025, 2:19 PM EST - 7 weeks ago

Wasatch Micro Cap Value Fund Q3 2025 Contributors And Detractors

BELFB LMB PMTS WLDN

Oct 29, 2025, 2:26 PM EDT - 2 months ago

Axogen, Inc. (AXGN) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 7:00 AM EDT - 2 months ago

Axogen, Inc. Reports Third Quarter 2025 Financial Results

Oct 1, 2025, 12:30 PM EDT - 3 months ago

Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN

Oct 1, 2025, 10:50 AM EDT - 3 months ago

AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm

Aug 25, 2025, 6:40 AM EDT - 4 months ago

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft

Aug 12, 2025, 5:17 AM EDT - 4 months ago

Axogen: Broad Range Of Outcomes Still Present, Opting To Remain Sidelined

Aug 5, 2025, 1:15 PM EDT - 5 months ago

Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 4:10 PM EDT - 5 months ago

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference

Jul 22, 2025, 4:05 PM EDT - 5 months ago

Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025

May 28, 2025, 8:00 AM EDT - 7 months ago

Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference

May 9, 2025, 3:21 PM EDT - 8 months ago

Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:05 AM EDT - 8 months ago

Axogen, Inc. Reports 2025 First Quarter Financial Results

Apr 24, 2025, 8:04 AM EDT - 8 months ago

Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025

Feb 25, 2025, 1:58 PM EST - 10 months ago

Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 7:10 AM EST - 10 months ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th

Feb 11, 2025, 4:58 PM EST - 11 months ago

Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025

Jan 10, 2025, 5:00 PM EST - 1 year ago

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jan 6, 2025, 8:01 PM EST - 1 year ago

Axogen: Well Placed To Capitalize Growth At Higher Multiples

Nov 9, 2024, 9:53 AM EST - 1 year ago

Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript

Sep 6, 2024, 7:00 AM EDT - 1 year ago

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

Aug 8, 2024, 2:10 PM EDT - 1 year ago

Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:05 AM EDT - 1 year ago

Axogen, Inc. Announces New Leadership Appointments

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Jul 1, 2024, 7:00 AM EDT - 1 year ago

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

Jun 24, 2024, 7:00 AM EDT - 1 year ago

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

May 28, 2024, 4:30 PM EDT - 1 year ago

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

May 5, 2024, 1:21 AM EDT - 1 year ago

AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript

May 2, 2024, 7:00 AM EDT - 1 year ago

Axogen, Inc Reports First Quarter 2024 Financial Results

Apr 29, 2024, 4:50 PM EDT - 1 year ago

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

Apr 16, 2024, 7:00 AM EDT - 1 year ago

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

Mar 5, 2024, 11:03 AM EST - 1 year ago

AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 7:00 AM EST - 1 year ago

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

Feb 13, 2024, 4:30 PM EST - 2 years ago

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

Feb 2, 2024, 4:15 PM EST - 2 years ago

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Jan 18, 2024, 5:00 PM EST - 2 years ago

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

Jan 4, 2024, 4:45 PM EST - 2 years ago

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

Jan 4, 2024, 4:40 PM EST - 2 years ago

Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025

Jan 4, 2024, 4:35 PM EST - 2 years ago

Axogen Announces Promotions on Research and Development Team

Dec 26, 2023, 4:15 PM EST - 2 years ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Dec 6, 2023, 7:00 AM EST - 2 years ago

Axogen Announces Transition of Finance Team Leadership

Dec 1, 2023, 5:00 PM EST - 2 years ago

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nov 7, 2023, 9:49 AM EST - 2 years ago

AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 7:00 AM EST - 2 years ago

Axogen, Inc. Reports 2023 Third Quarter Financial Results

Oct 18, 2023, 7:00 AM EDT - 2 years ago

Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023

dustin1101 Dec. 23 at 9:09 PM

$AXGN Next stop $38+ IMO. What a beast. $45 right now and they can have all my shares 😉.

0 · Reply

freeindeed Dec. 22 at 9:12 PM

$AXGN Here's a lump of coal for all you shorts. Sorry, you'll have to divide it.💩 Merry Christmas longs!

1 · Reply

isaacwilliams33 Dec. 17 at 8:32 PM

$AXGN ge

0 · Reply

dustin1101 Dec. 17 at 7:21 PM

$AXGN big $ deciding it’s not worth waiting any longer. In the face of a red mkt. I added some early today and on the first dip. Back to just over 10K shares strong.

0 · Reply

Niddi Dec. 17 at 5:50 PM

$AXGN Manipulated down after approval. Should gain at least 20-25% by the year end. One more good news will take it above 40. Just my opinion.

0 · Reply

dustin1101 Dec. 17 at 3:08 PM

$AXGN popping wood first thing today after the last two days is a good sign. Nice volume 👀

0 · Reply

Niddi Dec. 15 at 7:53 PM

$AXGN Is it alive?

0 · Reply

dustin1101 Dec. 15 at 5:08 PM

$AXGN If you’re making investing decisions based on AI generated crap like this below.. 🤦🏻‍♂️ wow.. ⬇️⬇️⬇️

0 · Reply

BioTechHealthX Dec. 13 at 11:22 PM

1 · Reply

Niddi Dec. 12 at 8:57 PM

$AXGN It’s amazing how easily a stock can be manipulated.

0 · Reply

dustin1101 Dec. 12 at 5:32 PM

$AXGN Looks to me like the insider sell programs are done.. 📈

0 · Reply

noor_solstice Dec. 11 at 8:18 PM

$AXGN Mainz Biomed at 1.05 with a 0.92 52-week low and a clear base tells me downside is defined but upside can open straight into 1.30+ on the first abnormal volume day 🔥📈

0 · Reply

dustin1101 Dec. 11 at 3:03 PM

$AXGN Planned insider sales and mkt pullback are providing a golden opportunity for entry before this resumes climb to fair value or possibly gets bought out. Added another 500 down here. Will put in another $50K if the price is right.. GL everyone!

0 · Reply

Pobr Dec. 11 at 11:03 AM

$AXGN what happened....?

0 · Reply

Niddi Dec. 10 at 7:33 PM

$AXGN Shorties can manipulate it down only temporarily but eventually it will go up. Accumulation going on although not many are selling. One good news/catalyst at this point and this will fly. 20-25% up from here. Let’s hope it sooner than later.

1 · Reply

Niddi Dec. 9 at 8:31 PM

$AXGN MM are at it. It will go up with in this week and next.

0 · Reply

dustin1101 Dec. 9 at 7:25 PM

$AXGN Looking good! Thanks for the discount shares, sellers… Not much available at those levels evidentially.

0 · Reply

dustin1101 Dec. 9 at 2:51 PM

$AXGN Added 600 here.

0 · Reply

Niddi Dec. 8 at 4:30 PM

$AXGN Pull back is expected. It will rise gradually to 35 over next 5 sessions. Just my observation.

0 · Reply

dustin1101 Dec. 8 at 3:22 PM

$AXGN If this goes a little lower I’ll be adding. Still easy money to be made. Just the impatient hitting the bid here.

0 · Reply

TheRoaringBunny Dec. 5 at 11:13 PM

$AXGN $CEP $FRSX $QURE You have less than 2 hours to grab $PLBY The next global meme stock runs on Monday

1 · Reply

dustin1101 Dec. 5 at 8:37 PM

$AXGN Analyst pt’s 34-40 with most closer to 40. I suspect we work toward that range. What would be the premium on a buyout?

0 · Reply

Market Cap	1.51B
Revenue (ttm)	187.34M
Net Income (ttm)	-9.96M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-5.32%
Debt to Equity Ratio	0.40

Volume	446,100
Avg Vol	908,494
Day's Range	N/A - N/A
Shares Out	46.12M
Stochastic %K	88%
Beta	1.06
Analysts	Strong Sell
Price Target	$36.55